Re-purposing of Lipid Lowering & Metabolic Therapeutics to Reduce the Severity of Covid-19 Infection in the Community
Posted at h
in COVID-19
International Research Collaboration to identify off-label common readily available and affordable drugs that may treat or ameliorate Covid-19 symptoms and reduce the need for medical review and/or hospitalisation.
We study the role of cholesterol level in the process of the coronavirus infection and focus on lipid lowering therapy especially statins which are relatively safe, commonly prescribed medication class which promote cholesterol reduction, plaque stabilization, cardiovascular risk prevention and have general anti‐inflammatory and potential antiviral properties.
Papers:
Cholesterol in Relation to COVID-19: Should We Care about It?
Statins and the COVID-19 main protease: in silico evidence on direct interaction